Scientists have developed software that can forecast the survival of patients diagnosed with glioma that is more accurate than doctors’ predictions.
Northwestern Medicine scientists usher in a new era of genetic research. Learn how our investigators are using CRISPR technology to isolate mutations that cause neurological diseases and to understand how individual genes can damage or protect cells.
Northwestern Medicine scientists have discovered mutations that cause improper drainage and a buildup of ocular pressure leading to glaucoma, suggesting a path towards future treatments.
A team from the academic and clinical arms of
Northwestern Medicine has been assembled to study patient DNA and create customized therapies for Parkinson’s, Epilepsy, and ALS in a model called Personalized Neurology.
Scientists are one step closer to a stem cell treatment for muscular dystrophy after Northwestern Medicine investigators demonstrated improvements in muscle tissue differentiation in stem cells.
Scientists reduced blood clotting in mice with a blood disease called myeloproliferative neoplasm by inhibiting expression of a gene.
A new $10 million gift from University trustees and supporters Louis A. Simpson ’58 and Kimberly K. Querrey will create a center to study the effects of environment on the activation and expression of genes.
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an Amish family in Indiana, according to a new Northwestern Medicine study.
Northwestern Medicine scientists have discovered that a protein called BRWD2/PHIP binds to H3K4 methylation, a key molecular event that influences gene expression.
Northwestern Medicine scientists have discovered a genetic basis for glaucoma symptoms and the impact of other genes in early retinal development.